S. Alzheimer’s This is the most common neurological degenerative diseases in the world, according to information from the Ministry of Health. In Brazil, about two million people live with a form of dementia. On a global scale, the situation affects more than 55 million people, according to the world report on Alzheimer’s 2024.
Increased risk of developing aging. Neurologist Jerusa SmidFrom the group of nerves and cognitive behavior in the hospital, Das Clinicas de São Paulo, he says this happens after the age of 65.
“After 65 years, we increase the chance of Alzheimer’s disease and bend the spread of this disease every five. So, for example, from 65 to 70, I have a chance. This opportunity doubles from 71 to 75 years, etc.,” explained the neurologist.
She is one of the guests Dr. Roberto KleelBesides a neurologist Sonia BrooklyThat coordinates the same group that is jerusa part, l “Biblical CNN Tags – Dr. Cleill’s interview” This Saturday (3).
Also discussed with nerve doctors K Herpes-ZustreKnown as Zostavax, Reduces the chances of developing Alzheimer’s disease. Immunization is suitable for all people over 50 years of age, with the exception of immune pregnant women, people with severe sensitivity to any vaccine components and people with uneducated tuberculosis.
“A few years ago, studies have shown that those who have a herpes vaccine in the Nub will have a lower chance to develop Alzheimer’s disease. Several studies have seen that spreading in those who were accompanying over the years, and who suffer from risk reduction by almost 50 %,” Brookly explained.
He added: “So, it is something that adds more to all these luxury factors to prevent dementia.”
What are the risk factors?
OS Risk factors to develop Alzheimer’s disease SMID said there are several, only 3 % of cases are associated with heredity, and it is considered very rare. “These are family cases usually occurring before the age of sixty,” he added.
Some of the most important risk factors include, according to Brucki, “high blood pressure, diabetes, vascular risk factors, sleep breathing, depression – especially depression that begins at the oldest adults -, physical inactivity, alcoholism, smoking, social isolation.” Therefore, prevented Alzheimer’s corridor through Healthy lifestyleThe doctor said.
Neuroscientists also discuss how The social factor can increase the chances of developing Alzheimer’s disease. “One of the main risk factors is education. So in the number of illiterate, the spread is higher and the disease reaches early,” explained SMID.
She also said that “the individual who has no primary care, does not care about high blood pressure, diabetes, and the heart, does not do physical activity, does not feed properly, and has a diet with superb treatment, which is also associated with dementia.” Alzheimer’s.
For Brucki, the union of these factors “leads to an insufficient formation of cognitive reserves”, responsible for increasing the number of clamps. He added, “Nerve cells increase their buds, and all of this will be achieved from a much stronger network for you to fight the disease,” he added.
According to her, there is evidence that shows that Literacy can double the risk of developing dementia in relation to people with at least one year of school.
“In Latin America, some studies have witnessed that individuals or more education have about 10 % of dementia; illiterate is 20 %,” he said.
New Alzheimer’s medicine
The National Health Control Agency (AnVisa) approved the drug Kisonla (Donnimabe), from the pharmacist Eli Lily de Brazil, to Alzheimer’s treatment in primary symptoms. This is the first drug that imposes penalties on it to slow down the development of the disease in adults of symptoms.
“It is used in a few cases, in the beginning, light dementia, or what we call poor light perception, which is a training period before the individual loses the autonomy.”
Brookly stated that Not all patients who have been diagnosed with Alzheimer’s can use medications Because of the possible serious side effects that the drug can cause.
Brookly concluded those who cannot take the drug: “Individuals with non -controlled high blood pressure cannot use them, with anticoagulants, individuals who have suffered a stroke in the past year, for example,” and Brookly relieved those who cannot take the drug.
“CNN Vital Signs – Dr. Kalil Interview” broadcast on Saturday, May 3, at 7:30 pm, at CNN Brazil.
Anvisa agrees to the first treatment that is considered to delay Alzheimer’s disease
